Innovation that improves lives

Unichem has defined priority areas for its research and development efforts that are aligned with the company’s business goals.

PROCESS R&D – GOA

Unichem‘s Generic R&D is completely backward integrated till the Active Pharmaceutical Ingredients (API) and Regulatory Starting Materials. The PR&D develops non-infringing, novel and economical chemical processes for APIs and intermediates. It develops processes for advance intermediates for NCEs and conducts NCE research for select pharmacological targets. The APIs developed are mainly used for in-house formulation development. Some of the APIs may be offered to the major generic players in international markets or to strategic business partners of Unichem.

priority_areas_new_img

FORMULATION R&D – GOA

The Formulation R&D facility aims at:

  • Developing formulations so that products can be sold in regulated markets (USA, Europe, East Europe and Brazil) as well as the local market
  • Selective contract formulation development for generic companies to tap regulated markets
  • Contract formulation development for NCE with multinational pharmaceutical research companies for regulated markets

BIOTECHNOLOGY R&D – GOA

Unichem has set up a biotechnology R&D centre with pilot plant facilities at Goa.